AACE endocrinology and diabetes · 2025
Long-term Hypertension Remission in People With Surgically Treated Primary Aldosteronism: A Single-Center Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chow Edith Wing Kar, Tsui Teresa Kam Chi, Cheng Timothy Hua-Tse, Liu Shirley Yuk Wah, Tam Claudia Ha-Ting, Ho Chung Shun, Cheng Jenny Yeuk-Ki, Cheung Kitty Kit Ting, Ozaki Risa, Luk Andrea On Yan, Ma Ronald Ching Wan
Аннотация
BACKGROUND/OBJECTIVE: Long-term remission rates of hypertension following adrenalectomy for primary aldosteronism (PA) varied across studies. We identified predictors for long-term and sustained hypertension remission among individuals with PA.
CASE REPORT: Patients who underwent unilateral adrenalectomy for PA at the Prince of Wales Hospital, Hong Kong from January 2000 to October 2022 were reviewed retrospectively. Clinical outcomes were assessed at 2 postsurgical time points: the first follow-up post-surgery and the last follow-up at the time of data retrieval. Complete clinical success is defined as normal blood pressure without the need for anti-hypertensive drugs. Logistic regression was performed to identify parameters and factors associated with complete clinical success at each of the time points and for sustained hypertension remission, defined as complete clinical success at both time points.
DISCUSSION: Eighty-nine patients were included. Median follow-up duration was 2.1 months and 113.4 months at the first and last post-surgery visit. Complete clinical success was achieved in 61% (N = 54) and 47% (N = 42) at the first and last post-surgery visit. A total of 27.8% (N = 15) of the patients who achieved complete clinical success at the first post-surgery visit did not have sustained hypertension remission. Female sex was associated with greater odds for sustained hypertension remission (odds ratio 4.04, 95% confidence interval 1.38-11.83) while diabetes was associated with reduced likelihood of sustained remission of hypertension (odds ratio 0.13, 95% confidence interval 0.02-0.70).
CONCLUSION: The prevalence of hypertension remission after adrenalectomy is 47% over a median follow-up of 9 years. Diabetes was associated with a lower odds of sustained hypertension remission.
CASE REPORT: Patients who underwent unilateral adrenalectomy for PA at the Prince of Wales Hospital, Hong Kong from January 2000 to October 2022 were reviewed retrospectively. Clinical outcomes were assessed at 2 postsurgical time points: the first follow-up post-surgery and the last follow-up at the time of data retrieval. Complete clinical success is defined as normal blood pressure without the need for anti-hypertensive drugs. Logistic regression was performed to identify parameters and factors associated with complete clinical success at each of the time points and for sustained hypertension remission, defined as complete clinical success at both time points.
DISCUSSION: Eighty-nine patients were included. Median follow-up duration was 2.1 months and 113.4 months at the first and last post-surgery visit. Complete clinical success was achieved in 61% (N = 54) and 47% (N = 42) at the first and last post-surgery visit. A total of 27.8% (N = 15) of the patients who achieved complete clinical success at the first post-surgery visit did not have sustained hypertension remission. Female sex was associated with greater odds for sustained hypertension remission (odds ratio 4.04, 95% confidence interval 1.38-11.83) while diabetes was associated with reduced likelihood of sustained remission of hypertension (odds ratio 0.13, 95% confidence interval 0.02-0.70).
CONCLUSION: The prevalence of hypertension remission after adrenalectomy is 47% over a median follow-up of 9 years. Diabetes was associated with a lower odds of sustained hypertension remission.